Delcath Systems Inc (DCTH)
US$ 11.72-2.25%
Price Chart
Key Statistics
Market Cap
$ 374.38M
P/E Ratio
0.00
Revenue (TTM)
$ 53.85M
Volume
469.38K
52W High
$ 18.23
52W Low
$ 7.17
Dividend Yield
0.00%
Beta
0.87
Technicals
50-Day MA
13.8236
200-Day MA
12.8957
52 Week High
18.23
52 Week Low
7.1701
About DCTH
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.
Employees
96
Headquarters
New York, NY
CEO
Mr. Gerard J. Michel MBA, MS
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg